This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Reply to Sertraline Versus Venlafaxine XR in Major Depressive Disorder

Richard C. Shelton, MD

Published: October 15, 2007

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: The point regarding the nature of the recruited sample in our study, "A Randomized, Double-Blind, Active-Control Study of Sertraline Versus Venlafaxine XR in Major Depressive Disorder," raised by Drs. Lusicic and Jagadheesan is well taken. The participating sites were outpatient clinics affiliated with large, tertiary-care referral centers, or large community clinics that were experienced in clinical trials. Patients were recruited from those who presented for care in the centers, by self- or word-of-mouth referrals, or in response to advertisements regarding the study.’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 68

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...